2009
Established
10,000
Attendees
1,500
Speakers
1,250
Companies
“PMWC has created an outstanding forum that touches every component of precision medicine and convenes all of its stakeholders.
I am honored to be part of this experience and to be able to influence the structure and focus of the upcoming PMWC 2017 SV conference.”
Keith Yamamoto, PhD, PMWC 2017 Silicon Valley Program Chair![How To Engage Community Oncologists in Precision Medicine Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/community-precision-oncology-400x284.jpg)
How To Engage Community Oncologists in Precision Medicine
Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair
![Immunotherapy: Emerging Applications and Therapies Session Chair: James Allison, MD Anderson Cancer Center](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/emerging-immunotherapies-James-Allison-400x284.jpg)
Immunotherapy: Emerging Applications and Therapies
Session Chair: James Allison, MD Anderson Cancer Center
![Human Biospecimen Acquisition; Risks, Challenges and Solutions Session Chair: Matt McLoughlin, Scientist.com](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/Freezer5-400x284.jpg)
Human Biospecimen Acquisition; Risks, Challenges and Solutions
Session Chair: Matt McLoughlin, Scientist.com
![CIAPM: Accelerating Precision Medicine Advances in California Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/CIAPM-1-400x284.jpg)
CIAPM: Accelerating Precision Medicine Advances in California
Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM
![How to Commercialize Disruptive Technologies That Advance Precision Medicine Session Chair: Alex De Winter, GE Ventures](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/handshake-400x284.jpg)
How to Commercialize Disruptive Technologies That Advance Precision Medicine
Session Chair: Alex De Winter, GE Ventures
![An Update on the Cancer Moonshot and Brain Government Initiatives Session Chair: Joshua Gordon, National Institute of Mental Health](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/government-initiatives-400x284.jpg)
An Update on the Cancer Moonshot and Brain Government Initiatives
Session Chair: Joshua Gordon, National Institute of Mental Health
![Health Systems as Translational Research Partners Session Chair: Walter “Buzz” Stewart, Sutter Health](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/translational-research-partners-400x284.jpg)
Health Systems as Translational Research Partners
Session Chair: Walter “Buzz” Stewart, Sutter Health
![Understanding Human Health and Diseases at the Individual Level Session Chair: Euan Ashley, Stanford Clinical Genomics Service](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/individual-human-health-400x284.jpg)
Understanding Human Health and Diseases at the Individual Level
Session Chair: Euan Ashley, Stanford Clinical Genomics Service
![Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges Session Chair: Walter Koch, Roche](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/blood-test-pipette_oncology-400x284.jpg)
Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges
Session Chair: Walter Koch, Roche
![Personalized Medicine – The Cinderella Story of Venture Investments? Session Chair: Mara Aspinall, Genepeeks](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/moneygenes-400x284.jpg)
Personalized Medicine – The Cinderella Story of Venture Investments?
Session Chair: Mara Aspinall, Genepeeks
![How Immuno-oncology Saved My Life: A Patient’s Perspective Session Chair: Andrew Schorr, Patient Power](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/Patient-Power-400x284.jpg)
How Immuno-oncology Saved My Life: A Patient’s Perspective
Session Chair: Andrew Schorr, Patient Power
![Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology Session Chair: Brad Gray, NanoString Technologies](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/immuno-oncology-400x284.jpg)
Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology
Session Chair: Brad Gray, NanoString Technologies
![Generating Insights from Multi-modal Healthcare Data for Precision Medicine Session Chair: Atul Butte, UCSF](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/advancing-healthcare-400x284.jpg)
Generating Insights from Multi-modal Healthcare Data for Precision Medicine
Session Chair: Atul Butte, UCSF
![Issues and Challenges of Immunotherapy Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/Immunotherapy-issues-and-challenges-400x284.jpg)
Issues and Challenges of Immunotherapy
Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center
![The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care Session Chair: Assaf Halevy, 2bPrecise](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/2bprecise-400x284.jpg)
The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care
Session Chair: Assaf Halevy, 2bPrecise
![Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine Session Chair: John Ryals, Metabolon](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/emerging-tech-session-400x284.jpg)
Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine
Session Chair: John Ryals, Metabolon
![Immunotherapy: Immunocheckpoint Inhibitors & Beyond Session Chair: Irv Weissman, Stanford School of Medicine](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/Immunocheckpoint-Irv-Weissman-session-400x284.jpg)
Immunotherapy: Immunocheckpoint Inhibitors & Beyond
Session Chair: Irv Weissman, Stanford School of Medicine
![Precision Medicine Patent Law Update Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/session-law-400x284.jpg)
Precision Medicine Patent Law Update
Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West
![How To Engage Community Oncologists in Precision Medicine Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/community-precision-oncology-400x284.jpg)
How To Engage Community Oncologists in Precision Medicine
Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair
![Immunotherapy: Emerging Applications and Therapies Session Chair: James Allison, MD Anderson Cancer Center](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/emerging-immunotherapies-James-Allison-400x284.jpg)
Immunotherapy: Emerging Applications and Therapies
Session Chair: James Allison, MD Anderson Cancer Center
![Human Biospecimen Acquisition; Risks, Challenges and Solutions Session Chair: Matt McLoughlin, Scientist.com](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/Freezer5-400x284.jpg)
Human Biospecimen Acquisition; Risks, Challenges and Solutions
Session Chair: Matt McLoughlin, Scientist.com
![CIAPM: Accelerating Precision Medicine Advances in California Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/CIAPM-1-400x284.jpg)
CIAPM: Accelerating Precision Medicine Advances in California
Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM
![How to Commercialize Disruptive Technologies That Advance Precision Medicine Session Chair: Alex De Winter, GE Ventures](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/handshake-400x284.jpg)
How to Commercialize Disruptive Technologies That Advance Precision Medicine
Session Chair: Alex De Winter, GE Ventures
![An Update on the Cancer Moonshot and Brain Government Initiatives Session Chair: Joshua Gordon, National Institute of Mental Health](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/government-initiatives-400x284.jpg)
An Update on the Cancer Moonshot and Brain Government Initiatives
Session Chair: Joshua Gordon, National Institute of Mental Health
![Health Systems as Translational Research Partners Session Chair: Walter “Buzz” Stewart, Sutter Health](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/translational-research-partners-400x284.jpg)
Health Systems as Translational Research Partners
Session Chair: Walter “Buzz” Stewart, Sutter Health
![Understanding Human Health and Diseases at the Individual Level Session Chair: Euan Ashley, Stanford Clinical Genomics Service](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/individual-human-health-400x284.jpg)
Understanding Human Health and Diseases at the Individual Level
Session Chair: Euan Ashley, Stanford Clinical Genomics Service
![Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges Session Chair: Walter Koch, Roche](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/blood-test-pipette_oncology-400x284.jpg)
Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges
Session Chair: Walter Koch, Roche
![Personalized Medicine – The Cinderella Story of Venture Investments? Session Chair: Mara Aspinall, Genepeeks](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/moneygenes-400x284.jpg)
Personalized Medicine – The Cinderella Story of Venture Investments?
Session Chair: Mara Aspinall, Genepeeks
![How Immuno-oncology Saved My Life: A Patient’s Perspective Session Chair: Andrew Schorr, Patient Power](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/Patient-Power-400x284.jpg)
How Immuno-oncology Saved My Life: A Patient’s Perspective
Session Chair: Andrew Schorr, Patient Power
![Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology Session Chair: Brad Gray, NanoString Technologies](https://past-711f.kxcdn.com/wp-content/uploads/2016/08/immuno-oncology-400x284.jpg)
Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology
Session Chair: Brad Gray, NanoString Technologies
![Generating Insights from Multi-modal Healthcare Data for Precision Medicine Session Chair: Atul Butte, UCSF](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/advancing-healthcare-400x284.jpg)
Generating Insights from Multi-modal Healthcare Data for Precision Medicine
Session Chair: Atul Butte, UCSF
![Issues and Challenges of Immunotherapy Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/Immunotherapy-issues-and-challenges-400x284.jpg)
Issues and Challenges of Immunotherapy
Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center
![The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care Session Chair: Assaf Halevy, 2bPrecise](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/2bprecise-400x284.jpg)
The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care
Session Chair: Assaf Halevy, 2bPrecise
![Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine Session Chair: John Ryals, Metabolon](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/emerging-tech-session-400x284.jpg)
Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine
Session Chair: John Ryals, Metabolon
![Immunotherapy: Immunocheckpoint Inhibitors & Beyond Session Chair: Irv Weissman, Stanford School of Medicine](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/Immunocheckpoint-Irv-Weissman-session-400x284.jpg)
Immunotherapy: Immunocheckpoint Inhibitors & Beyond
Session Chair: Irv Weissman, Stanford School of Medicine
![Precision Medicine Patent Law Update Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West](https://past-711f.kxcdn.com/wp-content/uploads/2016/07/session-law-400x284.jpg)
Precision Medicine Patent Law Update
Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West
Testimonials
“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”
Lee Hood, PhD, MD“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”
Peter Paul Yu, MD, FACP, FASCO“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”
Ed Abrahams, PhD